Drug manufacturer Mallinckrodt to pay $1.6 billion to settle opioid claims
Ireland-based Mallinckrodt announced Tuesday that it has tentatively agreed to pay $1.6 billion to settle thousands of lawsuits related to what Illinois and other states say is their role in the opioid epidemic.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
